NOVN.CH

97.24

-0.09%↓

NOVN.CH

97.24

-0.09%↓

NOVN.CH

97.24

-0.09%↓

NOVN.CH

97.24

-0.09%↓

NOVN.CH

97.24

-0.09%↓

Search

Sonova Holding AG

Open

SectorGezondheidszorg

246.3 -2.53

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

243.1

Max

254

Belangrijke statistieken

By Trading Economics

Inkomsten

209M

Verkoop

1.8B

K/W

Sectorgemiddelde

31.415

63.778

EPS

3.5

Dividendrendement

1.549

Winstmarge

11.379

EBITDA

417M

Aanbevelingen

By TipRanks

Aanbevelingen

Sell

12 Maanden Prognose

+5.82% upside

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-1.1B

18B

Vorige openingsprijs

248.83

Vorige sluitingsprijs

246.3

Nieuwssentiment

By Acuity

18%

82%

35 / 386 Rangschikking in Healthcare

Sonova Holding AG Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

10 sep 2024, 10:08 UTC

Belangrijke Marktbewegers

Hearing Aid Stocks Drop After Apple Adds Health Features to AirPods

Peer Vergelijking

Prijswijziging

Sonova Holding AG Prognose

Koersdoel

By TipRanks

5.82% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 271.33 CHF  5.82%

Hoogste 307 CHF

Laagste 224 CHF

Gebaseerd op 6 Wall Street-analisten die 12-maands prijsdoelen bieden voor Sonova Holding AG - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Sell

6 ratings

0

Buy

3

Hold

3

Sell

Sentiment

By Acuity

35 / 386 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Sonova Holding AG

Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands. The Cochlear Implants segment is involved in the design, development, manufacture, distribution, and service of hearing implants and related products under the Advanced Bionics brand. The company sells its products through independent distributors; and provides hearing care services through a network of stores and clinics. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. The company was founded in 1947 and is headquartered in Stäfa, Switzerland.